Page last updated: 2024-12-05

2-thiomalic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6268
CHEMBL ID4303414
CHEBI ID38705
SCHEMBL ID133541
MeSH IDM0133626

Synonyms (69)

Synonym
dl-mercaptosuccinic acid
wln: shyvq1vq
thiomalic acid
mercaptosuccinic acid
70-49-5
2-mercaptosuccinic acid
usaf ek-p-6297
butanedioic acid, mercapto-
nsc7302
.alpha.-mercaptosuccinic acid
nsc-7302
malic acid, 2-thio-
monomercaptosuccinic acid
succinic acid, mercapto-
2-thiomalic acid
NSC41809 ,
NCI60_003949
2-sulfanylbutanedioic acid
hstm
1-sulfanylethane-1,2-dicarboxylic acid
mercaptosuccinic acid, 97%
CHEBI:38705
alpha-mercaptosuccinic acid
2-sulfanylsuccinic acid
mercaptosuccinate
nsc 7302
einecs 211-423-7
(1)-mercaptosuccinic acid
brn 1099858
usaf m-2
ai3-22956
einecs 200-736-4
mercaptosuccinic acid, reagentplus(r), >=99.0% (hplc)
FT-0652864
M0064
AKOS000120969
BBL011516
STL146632
butanedioic acid, 2-mercapto-
unii-94239w5l4h
94239w5l4h ,
4-03-00-01130 (beilstein handbook reference)
sodium aurothiomalate impurity c [ep impurity]
dl-thiomalic acid
(+/-)-mercaptosuccinic acid
thiomalic acid [mi]
smr001826671
MLS006011445
SCHEMBL133541
AKOS016042329
2-mercapto-succinic acid
W-104552
STR07420
2-sulfanylsuccinic acid #
mfcd00004860
F2191-0218
DTXSID20861615
sr-01000945206
SR-01000945206-1
mercaptosuccinic acid, vetec(tm) reagent grade, 97%
mercaptosuccinicacid
CS-W010986
Q7784684
EN300-20552
CHEMBL4303414
D70319
SB45438
Z104478826
PD062592

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Potassium cyanide, a Cu,Zn-superoxide dismutase inhibitor, abolishes the toxic effect of Abeta(25-35) to erythrocytes, whereas mercaptosuccinate, a glutathione peroxidase inhibitor, and ouabain, a Na+,K+-ATPase inhibitor, promote it."( [Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Abeta25-35 to erythrocytes].
Kaminskiĭ, IuG; Kosenko, EA; Marov, NV; Pogosian, AS; Solomadin, IN; Venediktova, NI,
)
0.13
" Incubation of mitochondrial-enriched fractions with mercaptosuccinic acid, a GPx inhibitor, significantly augmented the toxic effects of MeHg administered in vivo."( Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase.
Bainy, AC; Dafre, AL; Dickson, PW; Dunkley, PR; Farina, M; Franco, JL; Marques, MR; Martins, R; Mattos, JJ; Posser, T, 2009
)
0.35
" However, the adverse effects of QDs on ECs are poorly understood."( An in vitro study of vascular endothelial toxicity of CdTe quantum dots.
Fu, T; Qin, H; Xu, K; Yan, M; Zhang, Y; Zheng, X, 2011
)
0.37
" Cytotoxicity experiments conducted on Escherichia coli cells revealed that CdSe QDs were the more toxic despite being the least loaded in cadmium."( Incidence of the core composition on the stability, the ROS production and the toxicity of CdSe quantum dots.
Balan, L; Kauffer, FA; Merlin, C; Schneider, R, 2014
)
0.4
" The results demonstrated that thiol-coating iron oxide magnetic nanoparticles have few toxic effects in cells, whereas S-nitrosated-coated particles did cause toxic effects."( Preparation, characterization, cytotoxicity, and genotoxicity evaluations of thiolated- and s-nitrosated superparamagnetic iron oxide nanoparticles: implications for cancer treatment.
de Lima, R; Ferrarini, AC; Haddad, PS; Pasquôto, T; Santos, Mda C; Seabra, AB, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
C4-dicarboxylic acidAny dicarboxylic acid that contains four carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (112)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (11.61)18.7374
1990's14 (12.50)18.2507
2000's24 (21.43)29.6817
2010's56 (50.00)24.3611
2020's5 (4.46)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.12 (24.57)
Research Supply Index4.77 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.71%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other115 (98.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]